Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma

NCT06111560 | Completed

• 1 other identifier: IIT-2023-282
• Study Type: observational
• Target: 160
• Locations: 0 countries
• Sites: N/A

Brief Summary

Patients with renal cell carcinoma who were admitted to the First Affiliated Hospital of Sun Yat-sen University from February 1, 2021, to February 1, 2022, and met the following inclusion and exclusion criteria were collected. Clinical factors influencing the prognosis of enrolled patients were retrospectively analyzed, and a predictive system was established based on this. (Inclusion criteria: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center. Exclusion criteria:a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up.)

Conditions

Carcinoma, Renal Cell

Outcome Measures

Primary Outcomes (1)

• Tumor progression

  medical imaging examinations showed tumor progression

  12 months

Study Arms (2)

Patients with tumor progression or recurrence

Patients enrolled in our retrospective study with tumor progression or recurrence

Other: We do not have any interventions. This study is based on obseravation.

Patients without tumor progression or recurrence

Patients enrolled in our retrospective study without tumor progression or recurrence

Other: We do not have any interventions. This study is based on obseravation.

Interventions

We do not have any interventions. This study is based on obseravation. OTHER

observational retrospective study without any interventions

Patients with tumor progression or recurrence; Patients without tumor progression or recurrence

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All the enrolled patients were Asian(we are a affiliated hospital of a university based in Mailand china ).

You may qualify if:

• a: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center

You may not qualify if:

• a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up

Sponsors & Collaborators

• Sun Yat-sen University: lead

MeSH Terms

Conditions

Carcinoma, Renal Cell

Condition Hierarchy (Ancestors)

Adenocarcinoma; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Neoplasms; Kidney Neoplasms; Urologic Neoplasms; Urogenital Neoplasms; Neoplasms by Site; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Kidney Diseases; Urologic Diseases; Male Urogenital Diseases

Study Officials

• Wenhui Su, Bachelor

  First affiliated hospital, Sun Yat-sen univeristy

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor,Phd,Md

Study Record Dates

• First Submitted: October 27, 2023
• First Posted: November 1, 2023
• Study Start: February 1, 2012
• Primary Completion: February 1, 2022
• Study Completion: February 1, 2022
• Last Updated: November 1, 2023

Record last verified: 2023-10